Zhang Y - Search Results

1

Efficacy and Safety of Befotertinib (D-0316) in Patients With EGFR T790M-Mutated NSCLC That Had Progressed After Prior EGFR Tyrosine Kinase Inhibitor Therapy: A Phase 2, Multicenter, Single-Arm, Open-Label Study.

Lu S, Zhang Y, Zhang G, Zhou J, Cang S, Cheng Y, Wu G, Cao P, Lv D, Jian H, Chen C, Jin X, Tian P, Wang K, Jiang G, Chen G, Chen Q, Zhao H, Ding C, Guo R, Sun G, Wang B, Jiang L, Liu Z, Fang J, Yang J, Zhuang W, Liu Y, Zhang J, Pan Y, Chen J, Yu Q, Zhao M, Cui J, Li D, Yi T, Yu Z, Yang Y, Zhang Y, Zhi X, Huang Y, Wu R, Chen L, Zang A, Cao L, Li Q, Li X, Song Y, Wang D, Zhang S, Ding L, Zhang L, Yuan X, Yao L, Shen Z. Lu S, et al. Among authors: zhang l, zhang s, zhang g, zhang j, zhang y. J Thorac Oncol. 2022 Oct;17(10):1192-1204. doi: 10.1016/j.jtho.2022.06.002. Epub 2022 Jun 18. J Thorac Oncol. 2022. PMID: 35724798 Free article. Clinical Trial.

2

EGFR mutations are associated with prognosis but not with the response to front-line chemotherapy in the Chinese patients with advanced non-small cell lung cancer.

Wu M, Zhao J, Song SW, Zhuo M, Wang X, Bai H, Wang S, Yang L, An T, Zhang Y, Duan J, Wang Y, Guo Q, Liu X, Liu N, Wang J. Wu M, et al. Among authors: zhang y. Lung Cancer. 2010 Mar;67(3):343-7. doi: 10.1016/j.lungcan.2009.04.011. Epub 2009 May 27. Lung Cancer. 2010. PMID: 19477549

3

Potential clinical significance of a plasma-based KRAS mutation analysis in patients with advanced non-small cell lung cancer.

Wang S, An T, Wang J, Zhao J, Wang Z, Zhuo M, Bai H, Yang L, Zhang Y, Wang X, Duan J, Wang Y, Guo Q, Wu M. Wang S, et al. Among authors: zhang y. Clin Cancer Res. 2010 Feb 15;16(4):1324-30. doi: 10.1158/1078-0432.CCR-09-2672. Epub 2010 Feb 9. Clin Cancer Res. 2010. PMID: 20145159

4

Expression of pro- and anti-angiogenic isoforms of VEGF in the mouse model of oxygen-induced retinopathy.

Zhao M, Shi X, Liang J, Miao Y, Xie W, Zhang Y, Li X. Zhao M, et al. Among authors: zhang y. Exp Eye Res. 2011 Dec;93(6):921-6. doi: 10.1016/j.exer.2011.10.013. Epub 2011 Nov 4. Exp Eye Res. 2011. PMID: 22067127

5

Single-agent maintenance therapy in non-small cell lung cancer: a systematic review and meta-analysis.

Yuan DM, Wei SZ, Lü YL, Zhang Y, Miao XH, Zhan P, Yu LK, Shi Y, Song Y. Yuan DM, et al. Among authors: zhang y. Chin Med J (Engl). 2012 Sep;125(17):3143-9. Chin Med J (Engl). 2012. PMID: 22932196 Review.

6

Risk of malignancy in focal thyroid lesions identified by (18)F-fluorodeoxyglucose positron emission tomography or positron emission tomography/computed tomography: evidence from a large series of studies.

Qu N, Zhang L, Lu ZW, Wei WJ, Zhang Y, Ji QH. Qu N, et al. Among authors: zhang l, zhang y. Tumour Biol. 2014 Jun;35(6):6139-47. doi: 10.1007/s13277-014-1813-4. Epub 2014 Mar 13. Tumour Biol. 2014. PMID: 24622887

7

Predictive and prognostic significance of circulating endothelial cells in advanced non-small cell lung cancer patients.

Yuan DM, Zhang Q, Lv YL, Ma XQ, Zhang Y, Liu HB, Song Y. Yuan DM, et al. Among authors: zhang q, zhang y. Tumour Biol. 2015 Nov;36(11):9031-7. doi: 10.1007/s13277-015-3657-y. Epub 2015 Jun 18. Tumour Biol. 2015. PMID: 26084612

8

Predictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature.

Qu N, Zhang L, Lu ZW, Ji QH, Yang SW, Wei WJ, Zhang Y. Qu N, et al. Among authors: zhang l, zhang y. Tumour Biol. 2016 Jun;37(6):7797-808. doi: 10.1007/s13277-015-4532-6. Epub 2015 Dec 22. Tumour Biol. 2016. PMID: 26695148

9

Efficacy and Safety of Neurokinin-1 Receptor Antagonists for Prevention of Chemotherapy-Induced Nausea and Vomiting: Systematic Review and Meta-analysis of Randomized Controlled Trials.

Yuan DM, Li Q, Zhang Q, Xiao XW, Yao YW, Zhang Y, Lv YL, Liu HB, Lv TF, Song Y. Yuan DM, et al. Among authors: zhang q, zhang y. Asian Pac J Cancer Prev. 2016;17(4):1661-75. doi: 10.7314/apjcp.2016.17.4.1661. Asian Pac J Cancer Prev. 2016. PMID: 27221836 Free article. Review.

10

MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner.

Shang Y, Zang A, Li J, Jia Y, Li X, Zhang L, Huo R, Yang J, Feng J, Ge K, Yang Y, Zhang Y, Jiang J. Shang Y, et al. Among authors: zhang l, zhang y. Biomed Pharmacother. 2016 Oct;83:1175-1181. doi: 10.1016/j.biopha.2016.08.006. Epub 2016 Aug 20. Biomed Pharmacother. 2016. PMID: 27551765

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

240,845 results

Search Page